FDA Person
FDALucila B. Nwatu
View detailed information about Lucila B. Nwatu, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 31 inspections of 29 companies, 2016–2026.
Inspections (31)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| August 18, 2026 | Imprimis NJOF, LLC | Not classified | #1316136 | |
| December 11, 2025 | Nubratori, Inc | Not classified | Drug Quality Assurance | #1294878 |
| July 16, 2025 | BSO LLC | OAI | Drug Quality Assurance | #1275884 |
| June 27, 2025 | BSO, LLC | OAI | Drug Quality Assurance | #1274469 |
| July 26, 2024 | Nubratori, Inc | OAI | Drug Quality Assurance | #1244125 |
| July 3, 2024 | BSO LLC | OAI | Drug Quality Assurance | #1243627 |
| March 15, 2019 | K & D Laboratories Inc | VAI | Drug Quality Assurance | #1083203 |
| February 28, 2019 | Rpk Pharmaceuticals Inc | VAI | Drug Quality Assurance | #1081636 |
| February 5, 2019 | SOFIE Co. dba SOFIE | VAI | Drug Quality Assurance | #1079123 |
| January 18, 2019 | Impax Laboratories, LLC. | NAI | Drug Quality Assurance | #1080691 |
| August 22, 2018 | Lonza Manufacturing LLC | VAI | Drug Quality Assurance | #1063110 |
| June 29, 2018 | Nature & Nature Co., Ltd. | OAI | Drug Quality Assurance | #1058056 |
| June 26, 2018 | Samsung Biologics Co., Ltd. | VAI | Drug Quality Assurance | #1056899 |
| June 15, 2018 | Hanmi Fine Chemical Co Ltd | VAI | Drug Quality Assurance | #1055911 |
| May 25, 2018 | PETNET Solutions, Inc. | VAI | Generic Drug Evaluation | #1053255 |
| March 8, 2018 | One Way Drug DBA Partell Specialty Pharmacy | OAI | Drug Quality Assurance | #1044255 |
| February 1, 2018 | Alza Corporation | VAI | Compliance: Devices | #1039728 |
| December 8, 2017 | Rigel Pharmaceuticals Inc | Not classified | #1035429 | |
| November 3, 2017 | Intersect ENT, Inc. | VAI | New Drug Evaluation | #1030747 |
| September 28, 2017 | High Tech Pharm Co., Ltd. | VAI | Drug Quality Assurance | #1035399 |
Documents (20)
- 483 · BSO, LLC · June 27, 2025
- 483 · AnazaoHealth Corporation · January 30, 2015
- 483 · Reliable Rexall-A Compounding Pharmacy · March 29, 2016
- 483 · Barclay Lake & Pillai Specialty Pharmacy PLLC · December 20, 2016
- 483 · One Way Drug DBA Partell Specialty Pharmacy · March 8, 2018
- 483 · BSO LLC · July 3, 2024
- 483 · Nubratori, Inc · July 26, 2024
- 483 · Nubratori, Inc · December 1, 2025
- 483 · Samsung Biologics Co., Ltd. · June 26, 2018
- 483 · Intersect ENT, Inc. · November 3, 2017
- 483 · Raptor Pharmaceuticals Inc. · August 24, 2016
- 483 · Hanmi Fine Chemical Co Ltd · June 11, 2018
- 483 · Genentech Inc · August 13, 2018
- 483 · SOFIE Co. dba SOFIE · February 5, 2019
- 483 · Rpk Pharmaceuticals Inc · February 25, 2019
- EIR · SOFIE Co. dba SOFIE · February 5, 2019
- 483 · Impax Laboratories, LLC. · May 4, 2016
- 483 · Nordmark Arzneimittel GMBH & Co. KG · February 13, 2017
- 483 · Imprimis NJOF, LLC · August 18, 2026
- EIR · C S Bio Co. · February 17, 2022
Frequently inspected with (10)
Person Information
Name
Lucila B. Nwatu
Title
National Program Expert- Pharmacy Compounding
Role
Regulatory Personnel
ID: 3d1c9670-8206-425c-bddd-32e395293042
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.